New York Oncology Hematology Technographics

Discover the latest software purchases and digital transformation initiatives being undertaken by New York Oncology Hematology and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 10 New York Oncology Hematology employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.

During our research, we have identified that New York Oncology Hematology has purchased the following applications: Liquid Web Cloud Servers for Application Hosting and Computing Services in 2018, Hotjar for Customer Experience in 2018, Proofpoint Essentials URL Defense for Secure Web Gateways (SWG) in 2020 and the related IT decision-makers and key stakeholders.

Our database provides customer insight and contextual information on which enterprise applications and software systems New York Oncology Hematology is running and its propensity to invest more and deepen its relationship with Liquid Web , Akamai , Hotjar or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.

We have been analyzing New York Oncology Hematology revenues, which have grown to $1.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for New York Oncology Hematology intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.